(Q34678033)

3 August 2017

1 reference

title

Locally advanced and metastatic bladder cancer (English)

1 reference

3 August 2017

Dreicer R

1

1 reference

3 August 2017

1 October 2001

1 reference

Current Treatment Options in Oncology

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

5

1 reference

3 August 2017

431-436

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-001-0048-y

3 August 2017

0 references

cites work

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

1 reference

12 December 2020

Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract

1 reference

12 December 2020

Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer

1 reference

12 December 2020

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy

1 reference

12 December 2020

Recent advances in bladder cancer chemotherapy

1 reference

12 December 2020

Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation

1 reference

12 December 2020

Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin

1 reference

12 December 2020

Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy

1 reference

12 December 2020

Hydronephrosis as a prognostic indicator in bladder cancer patients

1 reference

12 December 2020

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

12 December 2020

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

12 December 2020

The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma

1 reference

12 December 2020

Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study

1 reference

12 December 2020

Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules

1 reference

12 December 2020

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

12 December 2020

Small cell carcinoma of the bladder and prostate

1 reference

12 December 2020

Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial

1 reference

12 December 2020

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

1 reference

12 December 2020

Results of radiotherapy on ureteric obstruction in muscle-invasive bladder cancer

1 reference

12 December 2020

10.1007/S11864-001-0048-Y

Identifiers

DOI

1 reference

PubMed ID

12057106

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

12057106